Meet Retina Australia’s 2027 research grant recipients
Two new research projects will tackle different challenges in developing potential treatments for inherited...
October CEO update: recognition, connection and progress
October has been a month of recognition, connection and continued progress towards a future...
Encouraging early progress in Australian retinal implant trial for inherited retinal disease
Early observations from a participant with Stargardt disease offer...
Rewriting cell identity: meet Dr Daniel Urrutia-Cabrera, our 2026 Emerging Scientist
Daniel is working on a way to repair the...
CEO Message September 2026
Over the past few months, I have been thinking a lot about what exactly Retina Australia’s role can be in bringing our community together. One...
CEO Message August 2026
August has reinforced for me that one of Retina Australia’s greatest strengths is our ability to bring together people, expertise and resources around shared priorities to create greater impact....
Rosemary and Leighton Take Texas – Vision 2026
Our very own Rosemary Boyd OAM and Leighton Boyd AM attended the Retina International...
CEO Message July 2026
As we begin a new financial year, July has been a month of building momentum and investing in Retina Australia's future. Much of our work this month has happened behind...
May 2026 CEO Message from Jonathan Brookes
May marked my first 90 days as CEO of Retina Australia, an important milestone and an opportunity to reflect. The...
April 2026 CEO Message from Jonathan Brookes
April has been another important month of building momentum — strengthening our connection with the community, growing our organisational...
March 2026 CEO Message from Jonathan Brookes
As I complete my second month as CEO of Retina Australia, I’ve been focused on two key priorities: building...
Presentation to Professor Michael Kalloniatis of the 2025 Hall of Fame Award
Retina Australia was proud to recognise Professor Michael Kalloniatis...
Inaugural Message from CEO Jonathan Brookes.
I am thrilled to write to you as the new CEO of Retina Australia. It has been an exciting...
Retina Australia appoints Jonathan Brookes as new CEO.
Retina Australia, the national organisation committed to progressing its vision of “a world without...
2026 Research Grants awarded
The Board of Retina Australia is delighted to announce two new Research Grants awarded for 2026. Associate Professor Raymond Wong, from the Centre for Eye...
Australia Approves Second Treatment for Geographic Atrophy
Astellas' IZERVAY® (avacincaptad pegol) has been approved for use in Australia by the TGA Astellas...
New Director joins Retina Australia
Retina Australia directors are pleased to announce that following the Annual General Meeting held 11 October 2025, Norlizzah (Liz) Syed was appointed to the...
Retina Australia Awards 2025
Retina Australia is delighted to announce the two inaugural recipients of the Retina Australia Awards. 2025 Retina Australia Hall of Fame Award Professor Michael Kalloniatis is...
New Board Appointments
Retina Australia directors are thrilled to announce the recent appointment of Associate Professor Anai Gonzelez-Cordero and Dr Alexis (Ceecee) Britten-Jones to the Board. Anai and Ceecee have been long...
First treatment for geographic atrophy approved in Australia
Apellis' SYFOVRE® (pegcetacoplan) TGA Approved Apellis Pharmaceuticals, Inc. announced today that Australia’s Therapeutic Goods Administration...